Guardian Pharmacy Services, Inc. (GRDN)
NYSE: GRDN · Real-Time Price · USD
32.66
+0.01 (0.03%)
Feb 18, 2026, 4:00 PM EST - Market closed

GRDN Income Statement

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2024FY 2023FY 2022FY 2021FY 2020
Period Ending
Sep '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20
1,3901,2281,046908.91792.07735.96
Revenue Growth (YoY)
18.68%17.42%15.10%14.75%7.63%5.39%
Cost of Revenue
1,115984.04837.88723.04630.81588.96
Gross Profit
274.32244.37208.31185.87161.27147
Selling, General & Admin
212.01302.85143.91133.88118.09102.54
Operating Expenses
212.01302.85143.91133.88131.12114.05
Operating Income
62.31-58.4864.451.9930.1532.95
Interest Expense
-0.92-3.28-2.86-1.93-1.64-2.16
Other Non Operating Income (Expenses)
0.77-0.28-0.37-0.4-0.19-0.25
EBT Excluding Unusual Items
62.16-62.0461.1749.6628.3330.54
Merger & Restructuring Charges
------0.25
Other Unusual Items
-3.62-4.44-23.45---0.64
Pretax Income
58.55-66.4837.7249.6628.3329.66
Income Tax Expense
19.014.56----
Earnings From Continuing Operations
39.53-71.0337.7249.6628.3329.66
Minority Interest in Earnings
0.71-16.25-13.82-14.24-12.01-9.72
Net Income
40.24-87.2923.935.4216.3119.94
Preferred Dividends & Other Adjustments
22.7622.7623.9---
Net Income to Common
17.48-110.05-35.4216.3119.94
Net Income Growth
---32.52%117.12%-18.20%-8.29%
Shares Outstanding (Basic)
6362----
Shares Outstanding (Diluted)
6462----
EPS (Basic)
0.28-1.77----
EPS (Diluted)
0.28-1.77----
Free Cash Flow
68.1741.5956.2631.7549.2244.27
Free Cash Flow Per Share
1.070.67----
Gross Margin
19.74%19.89%19.91%20.45%20.36%19.97%
Operating Margin
4.48%-4.76%6.16%5.72%3.81%4.48%
Profit Margin
1.26%-8.96%-3.90%2.06%2.71%
Free Cash Flow Margin
4.91%3.39%5.38%3.49%6.21%6.02%
EBITDA
84.06-38.7182.6368.5546.6850.2
EBITDA Margin
6.05%-3.15%7.90%7.54%5.89%6.82%
D&A For EBITDA
21.7519.7718.2316.5616.5317.26
EBIT
62.31-58.4864.451.9930.1532.95
EBIT Margin
4.48%-4.76%6.16%5.72%3.81%4.48%
Updated Sep 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q